Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
NCT02517151 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2015-09-10
Summary
A phase 2, randomized, placebo controlled trial evaluating the effects of n intravenous iron supplementation on chronic fatigue in IBD patients with controlled disease.
Conditions
- Chronic Fatigue
- Inflammatory Bowel Disease
Interventions
- DRUG
-
Ferric carboxymaltose
- DRUG
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
NCT05456932 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome
NCT03457571 ·Status: COMPLETED
-
EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD
NCT06321887 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis
NCT03235752 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Iron Replacement in Patients With Iron Deficiency.
NCT01067547 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD
NCT02774057 ·Status: UNKNOWN ·Phase: PHASE4
-
Anemia in Inflammatory Bowel Disease
NCT02760940 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
NCT00152841 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease
NCT03466983 ·Status: COMPLETED ·Phase: PHASE4
-
Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
NCT00882414 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
NCT01340872 ·Status: COMPLETED ·Phase: PHASE3
-
Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia
NCT01823029 ·Status: COMPLETED ·Phase: NA
-
Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease
NCT04123990 ·Status: UNKNOWN ·Phase: NA
-
Modafinil For Fatigue in IBD: A Feasibility Randomised Controlled Trial
NCT07295834 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Maintenance Treatment of Iron Deficiency in IBD Patients
NCT00810004 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
NCT01352221 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy
NCT01428843 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Peri-operative Immunonutrition on Recurrence and Infections in Crohn's Disease Patients
NCT04014517 ·Status: UNKNOWN ·Phase: NA
-
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease
NCT01751152 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Dose-finding IMU-838 for Ulcerative Colitis
NCT03341962 ·Status: TERMINATED ·Phase: PHASE2
-
A Multidisciplinary Approach to Assessing and Treating Fatigue in Inflammatory Bowel Disease
NCT05906043 ·Status: UNKNOWN ·Phase: NA
-
Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis
NCT03151525 ·Status: UNKNOWN ·Phase: PHASE4
-
Fatigue Management in Quiescent IBD
NCT02709434 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
NCT03934216 ·Status: COMPLETED ·Phase: PHASE2
-
FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
NCT00810030 ·Status: COMPLETED ·Phase: PHASE3